SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS ARTICLE M impact

Royalty Pharma Q3 Adjusted EBITDA Beats Estimates, Raises 2026 Guidance

OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…

RPRX
SquawkNews Desk 1 updates Updated Nov 04, 2026, 12:40 PM UTC

Story updates

12:40:20 PM UTC
SquawkNews
Royalty Pharma eleva previsión de crecimiento de ingresos por regalías al 10%-11% para 2026 Roya

OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.(This story was created using…

Related stories

G R Infraprojects Reports September-Quarter Revenue of 23.25 Billion Rupees L impact | EARNINGS | Nov 04, 2026, 01:59 PM UTC G R Infraprojects Reports September-Quarter Consolidated Net Profit of 2.93 Billion Rupees M impact | EARNINGS | Nov 04, 2026, 01:58 PM UTC Pandora Raises 2026 EBIT Margin Guidance to 22.5%-23% Pandora raised its 2026 EBIT margin guidance to 22.5%-23%. M impact | EARNINGS | Nov 04, 2026, 01:57 PM UTC Pandora Raises 2026 Organic Growth Outlook to 2–3% M impact | EARNINGS | Nov 04, 2026, 01:57 PM UTC Insulet Q3 Net Income Rises, Issues FY26 Outlook Insulet reported third-quarter net income of $141.1 million, or $2.03 per diluted share, versus $87.6 million, or $1.24 per share, a year earlier. Adjusted net income rose 57.2% to M impact | EARNINGS | Nov 04, 2026, 01:54 PM UTC Kansai Nerolac Reports September-Quarter Consolidated Net Profit of 1.46 Billion Rupees M impact | EARNINGS | Nov 04, 2026, 01:54 PM UTC